| 000 | 01416 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250511175843.0 | ||
| 264 | 0 | _c19920416 | |
| 008 | 199204s 0 0 eng d | ||
| 022 | _a0026-895X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchachter, J B | |
| 245 | 0 | 0 |
_aCyclic AMP differentiates two separate but interacting pathways of phosphoinositide hydrolysis in the DDT1-MF2 smooth muscle cell line. _h[electronic resource] |
| 260 |
_bMolecular pharmacology _cMar 1992 |
||
| 300 |
_a587-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a8-Bromo Cyclic Adenosine Monophosphate _xpharmacology |
| 650 | 0 | 4 |
_aAlkylating Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aColforsin _xpharmacology |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 |
_aMuscle, Smooth _xmetabolism |
| 650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
| 650 | 0 | 4 | _aPertussis Toxin |
| 650 | 0 | 4 |
_aPhosphatidylinositols _xmetabolism |
| 650 | 0 | 4 |
_aPrazosin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 | _aProtein Kinase Inhibitors |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Purinergic _xdrug effects |
| 650 | 0 | 4 |
_aVirulence Factors, Bordetella _xpharmacology |
| 700 | 1 | _aWolfe, B B | |
| 773 | 0 |
_tMolecular pharmacology _gvol. 41 _gno. 3 _gp. 587-97 |
|
| 999 |
_c1318741 _d1318741 |
||